AU2370195A - Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells - Google Patents

Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells

Info

Publication number
AU2370195A
AU2370195A AU23701/95A AU2370195A AU2370195A AU 2370195 A AU2370195 A AU 2370195A AU 23701/95 A AU23701/95 A AU 23701/95A AU 2370195 A AU2370195 A AU 2370195A AU 2370195 A AU2370195 A AU 2370195A
Authority
AU
Australia
Prior art keywords
migration
vivo
fusion
cell lines
lines obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23701/95A
Inventor
Scott Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2370195A publication Critical patent/AU2370195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU23701/95A 1994-04-28 1995-04-27 Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells Abandoned AU2370195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23442994A 1994-04-28 1994-04-28
US234429 1994-04-28
PCT/US1995/005330 WO1995029704A1 (en) 1994-04-28 1995-04-27 Cell lines obtained by in vivo migration and by fusion with autoimmune cells

Publications (1)

Publication Number Publication Date
AU2370195A true AU2370195A (en) 1995-11-29

Family

ID=22881359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23701/95A Abandoned AU2370195A (en) 1994-04-28 1995-04-27 Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells

Country Status (2)

Country Link
AU (1) AU2370195A (en)
WO (1) WO1995029704A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334312A (en) * 1996-10-09 2000-10-27 Oxford Biomedica Ltd Use of mononuclear phagocytes and a binding agent in therapeutic drug delivery
CA2303663A1 (en) * 1997-09-23 1999-04-01 Oxford Biomedica (Uk) Limited Expression of genes in hematopoietic stem cells in hischaemic conditions
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002556A1 (en) * 1991-07-26 1993-02-18 University Of Rochester Cancer therapy utilizing malignant cells

Also Published As

Publication number Publication date
WO1995029704A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
AU566856B2 (en) Electrochemcial cell with fluoride in electrolyte
AU1840695A (en) Improvement in solar cell modules and method of making same
AU1915095A (en) Improvement in solar cell modules and method of making same
AU8581691A (en) Composite membranes and electrochemical cells containing them
AU2589095A (en) Cell membrane fusion composition and method
AU4581897A (en) Solar cell modules with improved backskin and methods for forming same
AU2023995A (en) Electrochemical cell
AU6580998A (en) Screening methods in eucaryotic cells
AU9087891A (en) Electrochemical cell
GB2281655B (en) Electrochemical cell
GB2280779B (en) Electrochemical cell
GB9600772D0 (en) Improvements in and relating to electrochemical cells
GB2305772B (en) Electrolyte solution and lead-acid batteries using the same
AU3233995A (en) Polyurethane based electrolytes for electrochemical cells and electrochemical cells using same
GB2281436B (en) Electrochemical cell
AU1705997A (en) Battery electrolyte pad with gelling agents and method
AU1226699A (en) Composite suitable for use in electrochemical cells
GB9406677D0 (en) Electrochemical cell
AU6468398A (en) Methods for producing polypeptides in respiratory-deficient cells
AU2370195A (en) Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells
AU4779093A (en) Solid, glyme-containing electrolytes and electrochemical cells produced therefrom
IL117594A0 (en) Gene expression in mammalian cells
AU1877697A (en) Electrochemical cell
AU1335699A (en) Modified microcarriers and their use in cell cryoconservation
GB9314760D0 (en) Improvements in or relating to electrochemical cells